Andrew A. Renshaw

Andrew A. Renshaw

Auto-generated profile, based on publicly available information

Andrew A. Renshaw

Department of Pathology Baptist Hospital and Miami Cancer Institute Miami Florida USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2010 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
ARAndrew A. Renshaw
Andrew A. Renshaw
BACKGROUND: Recently reported Bethesda terminology suggests the use of the term “atypical follicular cells” for thyroid fine‐needle aspirates. Previous work has suggested that some types of “atypical follicular cells” have different risks of malignancy. METHODS: The author reviewed the results of all thyroid aspirations with surgical resection performed during the past 13 years at our institution, subclassified the “atypical follicular cells,” and compared their relative risk of malignancy. RESULTS: During the 13 years in question, a total of 7089 cases were aspirated with 1331 resections. A total of 548 (14%) of all cases were classified as “atypical follicular cells,” and 204 (37%) were resected with an overall risk of malignancy of 25%. The risk of malignancy for atypical follicular cells subclassified as “rule out papillary carcinoma” was significantly higher (38%) than the other atypical cells. The risk of “rule out Hurthle cell neoplasm” was, at 7%, significantly lower than the other cases of atypical follicular cells (P<.001 and P<.02, respectively). CONCLUSIONS: Different types of “atypical follicular cells” have significantly different risks of malignancy. This disparity of risk should be communicated by the cytologist. Cancer (Cancer Cytopathol) 2010. © 2010 American Cancer Society.

25 March 2011 in Cancer Cytopathology
Verified
Journal Article
Open access
PDF file
ARAndrew A. Renshaw
Andrew A. Renshaw
BACKGROUND: Atypical cells of undetermined significance (AUS) in thyroid fine-needle aspirates (FNAs) may have poor interobserver agreement. Some authors have suggested that “atrophic” microfollicles should be diagnosed as benign. This laboratory sought to determine whether criteria for this diagnosis could be improved by subcategorizing cases into specific patterns, including the atrophic pattern, and determining their risk of malignancy. METHODS: A series of 7089 FNAs were reviewed and correlated with subsequent resection specimens. Cases of AUS were reviewed and subclassified. RESULTS: Cases could be subcategorized into the following categories: 1) atypical, papillary carcinoma cannot be ruled out, 2) atypical, Hürthle cell neoplasm can not be ruled out, 3) cellular atrophic pattern, 4) scant atrophic pattern, and 5) cytologic atypia alone. Cytologic atypia alone (50%) and both atrophic patterns (21% and 34%) had a significant risk of malignancy. CONCLUSIONS: The majority of AUS cases in thyroid FNA can be subcategorized into 5 different patterns, all with associated significant risk of malignancy. “Atrophic” microfollicles are a significant risk factor for malignancy and should not be diagnosed as benign on the basis of lack of cytologic atypia. Cancer (Cancer Cytopathol) 2011;. © 2011 American Cancer Society.

1 October 2009 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
JSJohn R Srigley
John R Srigley
PHPeter A Humphrey
Peter A Humphrey
MAMahul B Amin
Mahul B Amin
SCSam S Chang
Sam S Chang
LELars Egevad
Lars Egevad
MPMembers of the Cancer Committee, College of American Pathologists
Members of the Cancer Committee, College of American Pathologists

25 April 1997 in Cancer
Verified
Journal Article
Open access
PDF file
SGScott R. Granter
Scott R. Granter
ARAndrew A. Renshaw
Andrew A. Renshaw
BACKGROUND The chromophobe variant of renal cell carcinoma is a recently described and frequently unrecognized tumor. Because the prognosis of the chromophobe variant appears to be intermediate between that of oncocytoma and the clear cell variant of renal cell carcinoma, accurate diagnosis may be important for appropriate clinical management. METHODS A retrospective analysis of fine‐needle aspirations of four primary and two metastatic chromophobe renal cell carcinomas (five typical and one eosinophilic variant) with histologically confirmed primary tumors was performed. Hale's colloidal iron stain was strongly positive in a diffuse cytoplasmic pattern in all resected primary tumors. RESULTS All fine‐needle aspirations were characterized by cellular smears comprised of single cells and small groups of cells. The cytoplasm varied from granular to flocculent. A characteristic feature was the presence of occasional markedly enlarged, bizarre, often multinucleated cells, within a background of moderately atypical cells. Nuclear enlargement, hyperchromasia, pleomorphism, and outline irregularity were noted in all cases. These features imparted a koilocyte‐like appearance to many of the cells. Intranuclear pseudoinclusions were present in four cases and were numerous in two. CONCLUSIONS Both primary and metastatic chromophobe renal cell carcinomas have unique cytologic features that allow for their distinction from oncocytoma and other variants of renal cell carcinoma. Cancer (Cancer Cytopathol) 1997; 81:122‐8. © 1997 American Cancer Society.

1 January 2016 in Pathology
Verified
Journal Article
Closed access
ARAndrew A. Renshaw
Andrew A. Renshaw
EGEdwin W. Gould
Edwin W. Gould

22 May 2019 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
ARAndrew A. Renshaw
Andrew A. Renshaw
APAlex Powell
Alex Powell
JCJorge Caso
Jorge Caso
EGEdwin W. Gould
Edwin W. Gould